This study reports the first representative epidemiological prevalence data for back pain, and its correlates and potential risk factors, for the German working population. To reduce the negative impact of back pain the most promising behavioural and conditional prevention measures in the workplace would be to reduce carrying stress and to vary working posture. In addition, a more active, athletic lifestyle, plus the avoidance of being overweight, should provide an additional protective or preventive effect.
Our report supports the excellent effect and good tolerance of this novel therapy, and we propose the use of propranolol as first-line treatment for IH.
Aim: The medical and economic impact of back pain in terms of health care costs, lost working days, and early retirement is on the increase in Western industrialised nations. This paper investigates the prevalence of back pain in the German general population and the relationship between social factors, employment status and back pain. Subjects and methods: The first German Health Survey comprised a representative total sample of 6,235 persons between the ages of 18 and 79. The relationship between back pain and social, lifestyle and workplace-related factors was investigated using multivariable logistic regression analyses. Results: The 7-day prevalence for back pain in Germany was found to be 36%, and the 1-year prevalence was 59%. The prevalence rates were significantly higher in women, lower socioeconomic classes, non-athletes, smokers and those who are overweight. Depressed mood and allergies co-occurred with back pain more frequently than by chance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.